Paper Details

  1. Home
  2. Paper Details

Review article: the safety profile of tegaserod.

Author: SchoenfeldP

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Tegaserod is generally safe and well-tolerated for the treatment of irritable bowel syndrome with constipation. The most common side effect is diarrhea, which is usually mild and transient.
Paper Details　
Original Abstract of the Article :
Gastrointestinal symptoms are the most common side-effects of tegaserod therapy. In data pooled from Phase III randomized controlled trials in patients with irritable bowel syndrome with constipation, diarrhoea was reported by 8.8% of patients treated with tegaserod 6 mg b.d. vs. 3.8% of patients tr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1365-2036.2004.02182.x

データ提供：米国国立医学図書館（NLM）

Tegaserod: A Gut-Friendly Medication with a Favorable Safety Profile

Gastrointestinal issues can be a real pain, literally! This review examines the safety profile of tegaserod, a medication used to treat irritable bowel syndrome (IBS) with constipation. The researchers reviewed data from clinical trials to assess the common side effects and overall safety of tegaserod. Their findings suggest that tegaserod is generally well tolerated, with the most common side effect being mild and transient diarrhea. The review also found no evidence of serious adverse events like ischemic colitis, suggesting a favorable safety profile for this medication.

Tegaserod: A Safe Option for IBS with Constipation

The review concluded that tegaserod exhibits a favorable safety profile in patients with IBS with constipation. While diarrhea was the most common side effect, it was generally mild and transient. The lack of serious adverse events suggests that tegaserod could be a safe and effective treatment option for IBS with constipation.

Finding Relief from Irritable Bowel Syndrome

This review offers valuable information for individuals struggling with IBS with constipation. The findings suggest that tegaserod could be a safe and effective option, potentially providing much-needed relief from the symptoms of this condition. Remember, my dear friends, just like the desert traveler seeks water, those with IBS seek relief from their symptoms, and this research sheds light on a potential solution.

Dr.Camel's Conclusion

This review assesses the safety profile of tegaserod, a medication used to treat irritable bowel syndrome with constipation. The findings suggest that tegaserod is generally well tolerated, with a favorable safety profile and a low risk of serious adverse events. This research provides valuable information for individuals seeking relief from IBS with constipation.

Date :
  1. Date Completed 2005-04-12
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

15521852

DOI: Digital Object Identifier

10.1111/j.1365-2036.2004.02182.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.